MHLW
- Business Wire
Solasia Announces Submission of New Drug Application for Anti-cancer Drug DARINAPARSIN for Peripheral T-Cell Lymphoma in Japan
NDA filed in Japan ahead of anywhere else in the world New anti-cancer drug with a novel mechanism of action…
Read More » - Health
Takeda Announces Approval of Moderna’s COVID-19 Vaccine in Japan
Osaka, Japan: − The Ministry of Health, Labour and Welfare (MHLW) Grants Regulatory Approval of Moderna’s COVID-19 Vaccine (COVID-19 Vaccine…
Read More » - Business
Takeda Submits New Drug Application in Japan for Lanadelumab as a Preventive Treatment for Hereditary Angioedema Attacks
Osaka, Japan: — Lanadelumab is an investigational monoclonal antibody for the preventive treatment of hereditary angioedema (HAE) in patients 12…
Read More » - Health
Takeda Expands COVID-19 Vaccine Supply in Japan Through Partnership with Moderna and Government of Japan
Osaka, Japan: Three-way agreement among Takeda, Moderna and the Government of Japan’s Ministry of Health Labour and Welfare (MHLW) to…
Read More »